Author Page
The Lack of Effect of Routine Magnesium Administration on Respiratory Function in Mechanically Ventilated Patients
Therapy directed toward improving respiratory muscle strength has been advocated for patients with respiratory muscle weakness and respiratory failure once their conditions have been stabilized by initiation of mechanical ventilation. Along with malnutrition, hypomagnesemia is a recognized cause of both skeletal muscle weakness and of respiratory muscle weakness. Patients with chronic obstructive pulmonary disease admitted […]
Outcome of Patients Requiring Medical ICU Admission Following Bone Marrow Transplantation: Conclusion
While clearly related to prognostic score at the time of admission, the development of MOF during MICU hospitalization was also an important predictor of death. A number of studies have demonstrated a relationship between MOF and death in the ICU. Of the 24 nonsurvivors, all but 4 developed MOF during their MICU stay. All three […]
Outcome of Patients Requiring Medical ICU Admission Following Bone Marrow Transplantation: Discussion
We conclude that while the mortality rate for patients requiring mechanical ventilation after BMT is more than 96 percent for those patients without significant respiratory failure, there is a reasonable chance of MICU survival. Overall, 16 percent of patients required admission to the MICU after BMT. This figure varied from others reported in the literature; […]
Outcome of Patients Requiring Medical ICU Admission Following Bone Marrow Transplantation: Results
There were 229 BMTs performed at our institution (129 allogeneic transplants and 100 autologous transplants) between March 3, 1984 and March 26, 1991. During this period 36 of these patients (15.7 percent) had 43 admissions to the MICU. The admission data for these patients in terms of outcome are summarized in Table 1. There was […]
Outcome of Patients Requiring Medical ICU Admission Following Bone Marrow Transplantation: Methods
Over the past two decades, bone marrow transplantation (BMT) has become accepted as a standard treatment modality in adults with aplastic anemia (AA), acute lymphocytic leukemia (ALL), acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), lymphoma, and certain solid tumors. Prior to BMT, patients receive conditioning regimens that include myeloablative chemotherapy often accompanied by total-body […]